Page 14 - நாள்பட்ட ஜூலியார்ட் பெயர் சொட்டு மருந்து ட்ரெண்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நாள்பட்ட ஜூலியார்ட் பெயர் சொட்டு மருந்து ட்ரெண்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நாள்பட்ட ஜூலியார்ட் பெயர் சொட்டு மருந்து ட்ரெண்ட் Today - Breaking & Trending Today

Five herbal medicines show potent activity against Babesia duncani in the lab

Five herbal medicines show potent activity against Babesia duncani in the lab
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that five herbal medicines had potent activity compared to commonly-used antibiotics in test tubes against Babesia duncani, a malaria-like parasite found on the West Coast of the U.S. that causes the disease babesiosis.
Published in the journal
Frontiers in Cellular and Infection Microbiology, the laboratory study was funded in part by the Bay Area Lyme Foundation. Collaborating researchers were from Johns Hopkins Bloomberg School of Public Health, California Center for Functional Medicine, and FOCUS Health Group, Naturopathic. ....

United States , Sunjyak Schweig , Linda Giampa , Emily Henderson , Bay Area Lyme Foundation , Johns Hopkins Bloomberg School Of Public Health , Health Group , California Center , Area Lyme Foundation , West Coast , Infection Microbiology , Bay Area Lyme , Johns Hopkins Bloomberg School , Public Health , Functional Medicine , Scientific Advisory Board Member , African Christmas , Alternative Medicine , Lyme Disease , Red Blood Cells , ஒன்றுபட்டது மாநிலங்களில் , லிண்டா ஜியாம்பா , எமிலி ஹென்டர்சன் , வளைகுடா பரப்பளவு லைம் அடித்தளம் , ஜான்ஸ் ஹாப்கின்ஸ் ப்ளூம்பெர்க் பள்ளி ஆஃப் பொது ஆரோக்கியம் , ஆரோக்கியம் குழு ,

Medical experts call for better kidney care

Medical experts call for better kidney care
By Zhou Wenting in Shanghai |
chinadaily.com.cn |
Updated: 2021-03-10 11:27
Share
CLOSE
Leading medical experts call for a higher awareness of chronic kidney diseases, which afflict more than 150 million people in China, ahead of the World Kidney Day on March 11. [Photo by Zhou Wenting/chinadaily.com.cn]
Medical experts have called for a higher awareness of chronic kidney diseases, especially the type that afflicts young and middle-aged people, ahead of World Kidney Day on March 11.
According to World Health Organization figures released in December, kidney diseases have become one of the top 10 causes of death in the world. In China, more than 150 million people suffer from chronic kidney diseases. ....

Wang Niansong , Shanghai Jiao Tong University School Of Medicine , World Health Organization , European Medicines Agency , Drug Administration , World Kidney Day , Renji Hospital Affiliated , Shanghai Jiao Tong University School , Everest Medicines , United State Food , ஷாங்காய் ஜியாவோ நாக்கு பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , உலகம் கிட்நீ நாள் , ரென்ஜி மருத்துவமனை இணைந்த , ஷாங்காய் ஜியாவோ நாக்கு பல்கலைக்கழகம் பள்ளி , எவரெஸ்ட் மருந்துகள் , ஒன்றுபட்டது நிலை உணவு ,

New molecule passes toxicology testing to treat multiple sclerosis

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma. ....

Lopes Ferreira , Emily Henderson , Dissemination Centers Ridcs , Brazilian Multiple Sclerosis Association , Paulo Research Foundation , Butantan Institute Special Laboratory For Applied Toxinology , Research On Toxins , Zebrafish Network , South Asia , Butantan Institute , Special Laboratory , Applied Toxinology , Immune Response , Cell Signaling , Dissemination Centers , Toxicology Reports , Carla Lima , Zebrafish Platform , Multiple Sclerosis , Animal Model , Anti Inflammatory , In Vivo , லோப்ஸ் ஃபெரீரா , எமிலி ஹென்டர்சன் , பிரேசிலியன் பல ஸ்க்லரோசிஸ் சங்கம் , பாலொ ஆராய்ச்சி அடித்தளம் ,

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Researchers confirm new drug development route for treating multiple sclerosis, asthma
Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.
The venomous toadfish Thalassophryne nattereri contains a peptide (TnP) with anti-inflammatory and anti-allergic potential. Confirmation of this potential has now come via the zebrafish Danio rerio, a popular aquarium species native to South Asia that shares 70% of its genome with humans and is widely used as a model for in vivo trials in drug development.
The researchers tested TnP in D. rerio to measure its toxicity. In a little over a year, their research showed that the peptide is safe. It did not cause cardiac dysfunction or neurological problems in the toxicity tests they performed. ....

Lopes Ferreira , Emily Henderson , Dissemination Centers Ridcs , Brazilian Multiple Sclerosis Association , Paulo Research Foundation , Butantan Institute Special Laboratory For Applied Toxinology , Research On Toxins , Zebrafish Network , South Asia , Butantan Institute , Special Laboratory , Applied Toxinology , Immune Response , Cell Signaling , Dissemination Centers , Toxicology Reports , Carla Lima , Zebrafish Platform , Multiple Sclerosis , Animal Model , Anti Inflammatory , In Vivo , லோப்ஸ் ஃபெரீரா , எமிலி ஹென்டர்சன் , பிரேசிலியன் பல ஸ்க்லரோசிஸ் சங்கம் , பாலொ ஆராய்ச்சி அடித்தளம் ,

New study may lead to therapeutic strategies for chronic lung disease

New study may lead to therapeutic strategies for chronic lung disease
Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection.
The evidence suggests that activation of this immune cell a type of guardian cell called a dendritic cell serves as an early switch that, when activated, sets in motion a chain of events that drives progressive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD).
The new study, published in The
Journal of Immunology, opens the door to potential preventive or therapeutic strategies for chronic lung disease. More immediately, measuring the levels of these dendritic cells in clinical samples from patients hospitalized with a viral infection, such as influenza or COVID-19, could help doctors identify which patients are at high risk of respiratory failur ....

Michaelj Holtzman , Emily Henderson , Division Of Pulmonary , Scientists At Washington University School Of Medicine , Washington University School Of Medicine , Washington University School , Study Senior Author , Herman Seldin Professor , Critical Care , Lung Disease , Chronic Obstructive Pulmonary Disease , Dendritic Cell , எமிலி ஹென்டர்சன் , பிரிவு ஆஃப் நுரையீரல் , விஞ்ஞானிகள் இல் வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி , படிப்பு மூத்தவர் நூலாசிரியர் , ஹெர்மன் செல்தின் ப்ரொஃபெஸர் , முக்கியமான பராமரிப்பு , நுரையீரல் நோய் , நாள்பட்ட தடைசெய்யும் நுரையீரல் நோய் ,